Nektar Therapeutics (NKTR) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Nektar Therapeutics | 1.60 Bn | 1.04 Bn | 3.16 Mn | 284.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 284.58% |
| Dec 31, 2025 | -65.84% |
| Sep 30, 2025 | 36.28% |
| Jun 30, 2025 | 53.86% |
| Mar 31, 2025 | -20.04% |
| Dec 31, 2024 | 25.44% |
| Sep 30, 2024 | -53.62% |
| Jun 30, 2024 | -44.92% |
| Mar 31, 2024 | -36.79% |
| Dec 31, 2023 | -60.02% |
| Sep 30, 2023 | -38.61% |
| Jun 30, 2023 | -34.58% |
| Mar 31, 2023 | 13.18% |
| Dec 31, 2022 | 249.86% |
| Sep 30, 2022 | 95.79% |
| Jun 30, 2022 | -49.10% |
| Mar 31, 2022 | -54.72% |
| Dec 31, 2021 | -87.32% |
| Sep 30, 2021 | -3.27% |
| Jun 30, 2021 | 161.73% |
| Mar 31, 2021 | -33.86% |
| Dec 31, 2020 | 106.46% |
| Sep 30, 2020 | -31.25% |
| Jun 30, 2020 | -31.86% |
| Mar 31, 2020 | 112.68% |
| Dec 31, 2019 | -50.56% |
| Sep 30, 2019 | -63.46% |
| Jun 30, 2019 | -90.62% |
| Mar 31, 2019 | 206.71% |
| Dec 31, 2018 | 3,992.92% |
| Sep 30, 2018 | 485.41% |
| Jun 30, 2018 | 5,541.99% |
| Mar 31, 2018 | 48.23% |
| Dec 31, 2017 | -92.02% |
| Sep 30, 2017 | -40.02% |
| Jun 30, 2017 | -70.99% |
| Mar 31, 2017 | -67.64% |
| Dec 31, 2016 | 7.32% |
| Sep 30, 2016 | 236.34% |
| Jun 30, 2016 | 166.71% |
| Mar 31, 2016 | -43.96% |
| Dec 31, 2015 | 349.41% |
| Sep 30, 2015 | -41.21% |
| Jun 30, 2015 | -32.00% |
| Mar 31, 2015 | 299.01% |
| Dec 31, 2014 | -68.35% |
| Sep 30, 2014 | -51.07% |
| Jun 30, 2014 | -25.91% |
| Mar 31, 2014 | 13.71% |
| Dec 31, 2013 | 53.58% |
| Sep 30, 2013 | 532.72% |
| Jun 30, 2013 | -69.57% |
| Mar 31, 2013 | -80.79% |
| Dec 31, 2012 | 66.12% |
| Sep 30, 2012 | -75.96% |
| Jun 30, 2012 | 1,071.12% |
| Mar 31, 2012 | 560.37% |
| Dec 31, 2011 | -13.76% |
| Sep 30, 2011 | 233.24% |
| Jun 30, 2011 | -49.98% |
| Mar 31, 2011 | 9.30% |